Veradermics Completes IPO and Adopts New Governance Structure

Veradermics, Incorporated ( (MANE) ) has shared an announcement.

On February 5, 2026, Veradermics, Incorporated consummated its initial public offering and, in connection with the listing, filed a fifth restated certificate of incorporation in Delaware that became effective the same day. The new charter authorizes 200 million shares of common stock, eliminates all references to previously existing series of preferred stock, creates 25 million shares of undesignated preferred stock that can be issued in one or more series with board approval, and removes stockholders’ ability to act by written consent, signaling a shift toward more centralized board control and enhanced structural flexibility post-IPO. Also effective February 5, 2026, Veradermics’ amended and restated bylaws took effect, overhauling procedures for stockholder proposals and director nominations, modifying indemnification terms for directors and officers, and aligning the bylaws with the new charter, together establishing a modern governance framework as the company transitions to life as a public issuer.

More about Veradermics, Incorporated

Veradermics, Incorporated is a newly public company whose common stock has just begun trading following its initial public offering (IPO). The company is incorporated in Delaware and has structured its capital to include a large pool of authorized common and preferred shares, reflecting a focus on flexibility in future financing and corporate governance as it enters the public markets.

Find detailed analytics on MANE stock on TipRanks’ Stock Analysis page.